Abstract:Objective To explore the clinicopathological features,diagnosis,differential diagnosis and treatment of congenital hemangioma (CH).Methods The clinical data,pathological characteristics and treatment of 32 CH cases were analyzed retrospectively.Results There were 20 boys and 12 girls with a boy-to-girl ratio of 1.6∶1 and a median age of 43 months.All were unifocal lesions at head & neck region (n =8),trunk (n =12),upper extremities (n =5) and lower extremities (n =7).One lesion was detected by prenatal ultrasonography and the remainder was present at birth.Twenty-five lesions gradually expanded in size,3 lesions had slight regression and 4 cases showed no obvious changes.One lesion felt warm on palpation,one with sinus at the center of mass while the remainder had no local pain,swelling or ulceration.All lesions had normal preoperative results of blood routine and blood coagulation function.One child received a preoperative injection of sclerosant.However,mass had no regression.All cases underwent complete resection.One child of excessive intraoperative hemorrhage received blood transfusion postoperatively.The clinical types were rapidly involuting congenital hemangioma (RICH,n =3) and noninvoluting congenital hemangioma (NICH,n =29).NICH:Tumor was dominated by lobules of capillaries,separated by dense fibrous tissues containing lymphatic vessels and small arteriovenous structures.Small intralobular vessels were lined by endothelial cells with hobnailed nuclei.The center of lobule was occupied by stelliform vessels.RICH:Tumor was dominated by lobules of capillaries,similar to those seen in NICH,most intralobular vessels were atretic and the remainder diminished.Endothelial cells became flattened.Focal hemorrhagic necrosis,hemosiderosis and calcification were observed.Immunohistochemistry showed that all cases were negative for Glut1,positive for CD34(32/32),CD31 (32/32) and WT1 (32/32) and D2-40 was partially positive.Twenty-five cases were followed up for 3-25 months.Slight linear scar was present.Recurrence was not found.Conclusions CH is a benign vascular tumor whose diagnosis (RICH or NICH) depends upon clinical manifestations and pathological morphology.Clinically and pathologically,it needs to be differentiated from vascular malformation,infantile hemangiomas,kaposiform hemangioendothelioma and pyogenic granuloma.

Detection and Clinical Value of Bfgf in the Serum of Hemangioma Infants

The Role Of Serum Basic Fibroblast Growth Factor, Estradiol And Urine Basic Fibroblast Growth Factor In Differentiating Infantile Haemangiomas From Vascular Malformations

Role of Urinary Basic Fibroblast Growth Factor in Differentiating Hemangiomas from Vascular Malformation

[The Determination and Significance of VEGF in the Serum of Hemangioma Patients].

THE CHANGE OF ANGIOGENIN LEVELS IN THE SERUM AND URINE AND ITS EFFECTS ON CLINICAL STAGE DIAGNOSIS OF HEMANGIOMA

Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients.

Angiogenin: a potential serum marker of infantile hemangioma revealed by cDNA microarray analysis.

[The Diagnostic Value of Eight Serum Indices for Liver Fibrosis].

Expression and significance of hypoxia inducible factor-1α in different phases of hemangioma and vascular malformation in infants and children

Expressions of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Hemangioma

Serum Levels of Bfgf, TGFβ1, HGF and VEGF in Patients with Thyroid Gland Tumors

[Expression and Correlation of Mast Cell, Clusterin/apoJ and Transforming Growth Factor-Beta in the Different Stages of Human Dermal Hemangioma].

Clinical Value of Vascular Endothelial Growth Factor in the Diagnosis and Treatment of Common Malignant Tumors

Research Progress on Markers of Infantile Hemangioma

Management of congenital hemangioma: clinicopathological analysis of 32 cases

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

The Clinical Significance of Detecting Plasma Vascular Endothelial Growthfactor Concentration in Non-hodgkin's Lymphoma

[Expression of Proliferating Cell Nuclear Antigen in Hemangioma and Vascular Malformations].

Serum Vascular Endothelial Growth Factors Dection and Its Clinic Significance in Tumour Patients

Clinical Significance of Presence of Serum and Urinary Basic Fibroblast Growth Factor in Diagnosis of Bladder Cancer

[The Relationship Between the Expression of HIF-1alpha and the Angiogenesis in Infancy Hemangioma].